Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ARCON
Description:
An ambiguous name used for software and organizations, including a Rust streaming analytics runtime and architectural modeling tools.
Primary topic:
Head and Neck Cancer Studies (20%)
Related topics:
Head and Neck Cancer Studies (20%),
Cancer, Hypoxia, and Metabolism (9%)
OpenAlex ID:
keywords/arcon
Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
2002
·
Johannes H A M Kaanders
, Karien I E M Wijffels
, et al.
·
PubMed
·
414
Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial
2012
·
Geert O. Janssens
, Saskia E. Rademakers
, et al.
·
Journal of Clinical Oncology
·
283
ARCON: a novel biology-based approach in radiotherapy
2002
·
Johannes HAM Kaanders
, Johan Bussink
, et al.
·
The Lancet Oncology
·
282
GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON
2003
·
P J Hoskin
, A Sibtain
, et al.
·
British Journal of Cancer
·
240
PDF
ARCON: experience in 215 patients with advanced head-and-neck cancer
2002
·
Johannes H.A.M Kaanders
, Lucas A.M Pop
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
203
On reference models for collaborative networked organizations
2008
·
Luis M. Camarinha-Matos
, Hamideh Afsarmanesh
·
International Journal of Production Research
·
161
Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging
2002
·
Mark Rijpkema
, Johannes H.A.M Kaanders
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
127
The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON
2006
·
Ruth A. Jonathan
, Karien I.E.M. Wijffels
, et al.
·
Radiotherapy and Oncology
·
103
Detection and Specific Targeting of Hypoxic Regions within Solid Tumors: Current Preclinical and Clinical Strategies
2008
·
M. Bache
, M. Kappler
, et al.
·
Current Medicinal Chemistry
·
99
Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
1996
·
M Saunders
, S Dische
·
Europe PMC (PubMed Central)
·
82
Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
2014
·
Geert O. Janssens
, Saskia E. Rademakers
, et al.
·
Clinical Cancer Research
·
49
Accelerated Radiotherapy, Carbogen, and Nicotinamide (ARCON) in the Treatment of Advanced Bladder Cancer: Mature Results of a Phase II Nonrandomized Study
2008
·
Peter Hoskin
, Ana Rojas
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
44
Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study
1997
·
Michele I. Saunders
, Peter J. Hoskin
, et al.
·
Radiotherapy and Oncology
·
39
Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial
2013
·
Saskia E. Rademakers
, Ilse J. Hoogsteen
, et al.
·
Radiotherapy and Oncology
·
37
Multiple Etiologies of Tumor Hypoxia Require Multifaceted Solutions
2007
·
Mark W. Dewhirst
, Isabel Cardenas Navia
, et al.
·
Clinical Cancer Research
·
37
PDF
Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer
1998
·
Jacques Bernier
, Michael R.L. Stratford
, et al.
·
Radiotherapy and Oncology
·
37
ARCON—Current Status: Summary of a Workshop on Preclinical and Clinical Studies
1997
·
Juliana Denekamp
, John F. Fowler
·
Acta Oncologica
·
36
PDF
Acute Effects of Accelerated Radiotherapy in Combination with Carbogen Breathing and Nicotinamide (Arcon)
1994
·
Björn Zackrisson
, Lars Franzén
, et al.
·
Acta Oncologica
·
35
PDF
Clinical Outcome and Tumour Microenvironmental Effects of Accelerated Radiotherapy with Carbogen and Nicotinamide
1999
·
Johan Bussink
, J H Kaanders
, et al.
·
Acta Oncologica
·
32
PDF
Computed tomography-based tumour volume as a predictor of outcome in laryngeal cancer: Results of the phase 3 ARCON trial
2014
·
Geert O. Janssens
, Liselotte W. van Bockel
, et al.
·
European Journal of Cancer
·
31
Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial
2013
·
Monique M. Nijkamp
, Paul N. Span
, et al.
·
European Journal of Cancer
·
31
The ARCON modeling framework
2008
·
Afsarmanesh, H.
, Camarinha-Matos, L.M.
, et al.
·
Springer eBooks
·
31
Strategies to overcome accelerated repopulation and hypoxia—what have we learned from clinical trials?
2004
·
June Corry
, Danny Rischin
·
Seminars in Oncology
·
31
Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide
2005
·
Peter J. Hoskin
, Ana M. Rojas
, et al.
·
Cancer
·
29
Towards a Novel Modular Architecture for Cern Radiation Monitoring
2016
·
Hamza Boukabache
, Michel Pangallo
, et al.
·
Radiation Protection Dosimetry
·
26
PDF
Show more works
View as search
Works count:
111
Citation count:
2,714
Year
Topic
Type